Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Jieakesu Su"'
Autor:
Minying Deng, Xin Liu, Yan Jiang, Rongkui Luo, Lei Xu, Xiaolei Zhang, Jieakesu Su, Chen Xu, Yingyong Hou
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-21 (2024)
Abstract To date, there have been no reports on tertiary lymphoid structures (TLS) in primary adenocarcinoma of jejunum and ileum. In this study, we employed digital pathology image analysis software to classify and quantify TLS, and evaluated the ma
Externí odkaz:
https://doaj.org/article/bd2cd3ddb81c490c831587f6dddf7a58
Autor:
Qi Song, Ye Yang, Dongxian Jiang, Zhaoyu Qin, Chen Xu, Haixing Wang, Jie Huang, Lingli Chen, Rongkui Luo, Xiaolei Zhang, Yufeng Huang, Lei Xu, Zixiang Yu, Subei Tan, Minying Deng, Ruqun Xue, Jingbo Qie, Kai Li, Yanan Yin, Xuetong Yue, Xiaogang Sun, Jieakesu Su, Fuchu He, Chen Ding, Yingyong Hou
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-20 (2022)
Squamous cell carcinomas are an aggressive cancer type which can occur in multiple organ systems. Here, the authors analyse the proteome of SCC cancers from 17 organs and show commonly dysregulated proteins independent of location.
Externí odkaz:
https://doaj.org/article/05d0671cbe88464bab2dc69a85f38421
Autor:
Dongxian Jiang, Qi Song, Han Tang, Peng Shi, Xiaolei Zhang, Yufeng Liu, Haixing Wang, Minying Deng, Jie Huang, Jieakesu Su, Chen Xu, Lijie Tan, Yingyong Hou
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
AimsThe distribution of residual esophageal squamous cell carcinoma (ESCC) in the esophageal wall and resected lymph nodes was evaluated after neoadjuvant chemoimmunotherapy (nICT).Methods and resultsClinical data were collected from 137 ESCC patient
Externí odkaz:
https://doaj.org/article/5c24ede642924cd28b8bf55283e073e8
Autor:
Dongxian Jiang, Qi Song, Xiaojun Wei, Zixiang Yu, Yufeng Liu, Haixing Wang, Xingxing Wang, Jie Huang, Jieakesu Su, Yang Hong, Yifan Xu, Chen Xu, Yingyong Hou
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundDNA mismatch repair (MMR) deficiency (dMMR) has been recognized as an important biomarker for immunotherapy in esophageal squamous cell carcinoma (ESCC), along with programmed death ligand 1 (PD-L1) expression and/or tumor-infiltrated lymph
Externí odkaz:
https://doaj.org/article/2b2c3aec4fb24d73ad80a0e414cb3ca4
Autor:
Yanqiu Wang, Zhengzeng Jiang, Chen Xu, Hao Wang, Lijie Tan, Jieakesu Su, Xin Wang, Dongxian Jiang, Yingyong Hou, Qi Song
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Backgrounds Since Mesenchymal epithelial transition (MET) amplification has been regarded as a potential treatment target, the knowledge of its prevalence and prognostic importance is crucial. However, its clinical pathologic characteristics
Externí odkaz:
https://doaj.org/article/5bccfb92ca024ffcbf052551f0073cfe
Autor:
Jie Huang, Xiang Wang, Xue Zhang, Weijie Chen, Lijuan Luan, Qi Song, Hao Wang, Jia Liu, Lei Xu, Yifan Xu, Licheng Shen, Lijie Tan, Dongxian Jiang, Jieakesu Su, Yingyong Hou
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
In the present study, we aimed to investigate the clinical and prognostic values of CDK4 amplification and improve the risk stratification in patients with esophageal squamous cell carcinoma. CDK4 amplification was analyzed by fluorescence in situ hy
Externí odkaz:
https://doaj.org/article/41cfdbe3eea940f28848ec30a99b4c41
Autor:
Chen Xu, Yalan Liu, Xiaowen Ge, Dongxian Jiang, Ying Zhang, Yuan Ji, Jun Hou, Jie Huang, Jieakesu Su, Haiying Zeng, Jing Qin, Yingyong Hou
Publikováno v:
Diagnostic Pathology, Vol 12, Iss 1, Pp 1-11 (2017)
Abstract Background HER2 assessment in biopsy specimens of gastric cancer (GC) is challenging because of the intratumoral heterogeneity. False negative results may be get because of limited biopsy material. The aim of this study is to explore how tum
Externí odkaz:
https://doaj.org/article/08d3d15e42ae43e1984a937556d5f844
Autor:
Dongxian Jiang, Haixing Wang, Minying Deng, Qi Song, Yufeng Liu, Rui Peng, Lei Xu, Jieakesu Su, Chen Xu, Yingyong Hou
Publikováno v:
European Journal of Surgical Oncology. 49:958-963
Recently, the number of diagnosed esophageal basaloid squamous cell carcinoma (EBSCC) has gradually increased. However, available data on EBSCC are limited to date.A total of 165 EBSCC (Cohort 1) and 515 conventional esophageal squamous cell carcinom
Autor:
Lili Zhang, Lijuan Luan, Licheng Shen, Ruqun Xue, Jie Huang, Jieakesu Su, Yufeng Huang, Yifan Xu, Xiang Wang, Yang Shao, Yuan Ji, Chen Xu, Yingyong Hou
Publikováno v:
Virchows Archiv. 482:567-580
Autor:
Zixiang Yu, Dongxian Jiang, Wen Huang, Rongkui Luo, Haixing Wang, Jieakesu Su, Jia Liu, Chen Xu, Yingyong Hou
Publikováno v:
Journal of Clinical Pathology; Nov2023, Vol. 76 Issue 11, p757-762, 9p